According to Edwards Lifesciences latest financial reports the cash on hand of EW is $1.64B, an increase of 35.32% to 2022. At the end of 2022 company had $1.22B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.64B | 35.32% |
2022 | $1.22B | -17.15% |
2021 | $1.47B | 4.58% |
2020 | $1.40B | -7.54% |
2019 | $1.52B | 58.59% |
2018 | $956.50M | - |